Mapping the literature for the passenger shipping industry
 
More details
Hide details
1
Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece
 
2
Healthy Sailing Project, Greece
 
3
EU SHIPSAN Scientific Association, Larissa, Greece
 
4
Department of Immunology and Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece
 
 
Publication date: 2025-12-05
 
 
Popul. Med. 2025;7(Supplement 1):A17
 
KEYWORDS
ABSTRACT
Introduction:
Infectious disease risks related to passenger ship travel are documented among cruise, ferry, river cruise and expedition ships1-5. Studies examining risk factors and success of control measures inform evidence-based guidelines and practices. However, emerging infections generate new evidence. COVID-19 emphasized the need for updated guidelines and practices. This scoping review maps literature currently informing passenger ship infection prevention and control strategies.

Methods:
The scoping review was conducted in accordance with PRISMA-ScR. PubMed, Scopus and grey literature were searched for scientific articles, legislation, guidelines and policies on infection prevention and control related to passenger ships (cruise, ferry, river cruise, expedition) and seaports between 1990-2023. Publications were categorised by: infectious disease, maritime setting, population, geographic region and measures.

Results:
The review identified 620 publications, primarily scientific articles (58%) and guidelines (28%). The majority of technical guidelines (68%) were at regional or national level, with fewer guidance documents available at international level. Technical guidance documents originated from various sources, including 48 publications from the World Health Organization, followed by 33 documents from previous European joint actions (HEALTHY GATEWAYS, SHIPSAN ACT). Infectious disease prevention and control in cruise ships was addressed approximately four times more than any other passenger ship type. From all eligible publications, seaports were addressed by approximately 30% of publications, while seaport communities were only referenced by approximately 5% of publications.

Conclusions:
Most literature focused on cruise ships, indicating a more robust evidence-base in this setting. Comparatively less scientific literature focused on other ship types or seaports. A generic approach is needed for preparedness planning in the maritime sector, addressing both known and unknown infectious disease events. Further research should create context-specific guidelines for all types of infection prevention and control in ferries, river cruise, expedition ships and seaports.
ACKNOWLEDGEMENTS
We would like to thank the HEALTHY SAILING project consortium and the HEALTHY GATEWAYS joint action consortium.
CONFLICTS OF INTEREST
None declared.
FUNDING
HEALTHY SAILING project has received funding from the European Union’s Horizon Europe Framework Programme (HORIZON) under Grant Agreement number 101069764. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Climate, Infrastructure and Environment Executive Agency (CINEA). Neither the European Union nor the granting authority can be held responsible for them. This work was funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10040786], [grant number 10040720]. This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI). Moreover, part of this research was conducted in the framework of the EU Healthy Gateways Joint Action, which received funding from the European Union’s Health Programme (2014–2020) under grant agreement no. 801493.
ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval and informed consent were not required for this study.
REFERENCES (5)
1.
Ward KA, Armstrong P, McAnulty JM, Iwasenko JM, Dwyer DE. Outbreaks of pandemic (H1N1) 2009 and seasonal influenza A (H3N2) on cruise ship. Emerging Infectious Diseases. 2010;16(11):1731-1737.
 
2.
Plucinski MM, Wallace M, Uehara A, et al. Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2021;72(10):e448-e457.
 
3.
Hatzianastasiou S, Mouchtouri VA, Pavli A, et al. COVID-19 Outbreak on a Passenger Ship and Assessment of Response Measures, Greece, 2020. Emerging Infectious Diseases. 2021;27(7):1927-1930.
 
4.
Gravningen K, Henriksen S, Hungnes O, et al. Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway. International Journal of Infectious Diseases. 2022;118:10-20.
 
5.
Wang X, Yong W, Shi L, et al. An outbreak of multiple norovirus strains on a cruise ship in China, 2014. Journal of Applied Microbiology. 2016;120(1):226-233.
 
eISSN:2654-1459
Journals System - logo
Scroll to top